EUROPEAN UROLOGY : Impact Factor & More
eISSN: 1873-7560pISSN: 0302-2838
Share this on:
Key Metrics
Eigenfactor 
0.05 - 0.1
Impact Factor
20 - 25
Scite Index
0.85 5-Year SI
SJR
Q1Urology
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on EUROPEAN UROLOGY
EUROPEAN UROLOGY Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1975 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in EUROPEAN UROLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in EUROPEAN UROLOGY
Reply to the Harry Herr's Letter to the Editor re: Oscar Buisan, Pol Servian, Sonia Pedreño-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.014.
- 23 Jan 2026
- European urology
Reconstruction of a Devastated Ureter: Multi-institutional Experience with Robotic Intracorporeal Ileal Ureter Replacement.
- 22 Jan 2026
- European urology
Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial.
- 21 Jan 2026
- European urology
Refining Salvage Radiotherapy After Prostatectomy: Positron Emission Tomography-guided Dose Escalation in EMPIRE-2.
- 17 Jan 2026
- European urology
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial.
- 17 Jan 2026
- European urology
The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer.
- 14 Jan 2026
- European urology
Reply to the Harry Herr's Letter to the Editor re: Oscar Buisan, Pol Servian, Sonia Pedreño-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.014.
- 23 Jan 2026
- European urology
Reconstruction of a Devastated Ureter: Multi-institutional Experience with Robotic Intracorporeal Ileal Ureter Replacement.
- 22 Jan 2026
- European urology
Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial.
- 21 Jan 2026
- European urology
Refining Salvage Radiotherapy After Prostatectomy: Positron Emission Tomography-guided Dose Escalation in EMPIRE-2.
- 17 Jan 2026
- European urology
Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial.
- 17 Jan 2026
- European urology
The Discovery of Prostate-specific Membrane Antigen Ligands: The Long Road to Changes in Clinical Practice for Prostate Cancer.
- 14 Jan 2026
- European urology
FAQs on EUROPEAN UROLOGY
How long has EUROPEAN UROLOGY been actively publishing? 
What is the publishing frequency of EUROPEAN UROLOGY?
How many articles did EUROPEAN UROLOGY publish last year?
What is the eISSN & pISSN for EUROPEAN UROLOGY?
What is the SJR for EUROPEAN UROLOGY?
Who is the publisher of EUROPEAN UROLOGY?
